CanSinoBIO Delivers Q1 Revenue Growth Amid Accelerating International Expansion

HONG KONG, Apr 28, 2026 - (ACN Newswire via SeaPRwire.com) - CanSino Biologics Inc. (688185.SH/06185.HK) released its first-quarter 2026 results, reflecting a positive operational momentum. Revenue for the quarter totaled RMB 190 million, representing a 38.73% year-over-year increase.The performance highlights the company’s strong operational resilience, driven by accelerating sales of…

ICONIC21 finalizes full portfolio distribution with Hub88

(AsiaGameHub) -   ICONIC21 has hit a major milestone in its business journey by finalizing an all-encompassing content agreement with Hub88. Press release.- ICONIC21 has achieved a key milestone in its commercial path by finalizing a comprehensive content deal with Hub88. Hub88 has integrated ICONIC21’s entire multi-vertical portfolio, giving its…

Empowered by Pipeline and Forged by Technology: Mabwell Successfully Lists on the Main Board of HKEX

HONG KONG, Apr 28, 2026 - (ACN Newswire via SeaPRwire.com) - Driven by the continuous innovation in global biopharmaceutical technology, the steady rollout of favorable policies, and escalating clinical demands, the biopharmaceutical industry is ushering in a golden cycle of development. As a representative enterprise in China's innovative pharmaceutical sector, Mabwell…